信邦制药：关于变更签字注册会计师的公告

Group 1 - The company announced a change in the signing auditor for the 2025 fiscal year from Yu Yongchun to Xu Ruixing [1] - The project partner remains Wang Xiaoming, and the quality control reviewer continues to be Huang Haiyang [1] - Beijing Dehao International Accounting Firm has issued a statement regarding the change, confirming that the transition has been orderly and will not affect the 2025 financial report and internal control audit [1]